ASPIRE BIOPHARMA HOLDINGS, INC. (ASBPW) Operating cash flow 2022–2025
ASPIRE BIOPHARMA HOLDINGS, INC. (ASBPW) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$4.9MFY2025 · since FY2022: -$1.4M → -$4.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$4.9M | -1756.6% |
| FY2024 | -$265,186 | +59.4% |
| FY2023 | -$653,107 | +53.6% |
| FY2022 | -$1.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ASBPW financial trends
ASBPW RevenueASBPW Net incomeASBPW Net marginASBPW Gross profitASBPW Gross marginASBPW Operating incomeASBPW Operating marginASBPW Free cash flowASBPW Capital expendituresASBPW Return on equityASBPW Stock buybacksASBPW Dividends paidASBPW Total assetsASBPW Total liabilitiesASBPW Shareholders’ equityASBPW overview →